• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Volato Group Announces $2.2 Million Strategic Investment and AI Infrastructure Acquisition Focus

    6/8/26 6:15:00 AM ET
    $SOAR
    $VTAK
    Transportation Services
    Consumer Discretionary
    Medical/Dental Instruments
    Health Care
    Get the next $SOAR alert in real time by email

    Investment strengthens balance sheet as Company evaluates non-binding AI infrastructure and technology transaction opportunities

    Volato Group, Inc. (NYSE:SOAR) (the "Company" or "Volato"), a technology company focused on building scalable software and data solutions that improve the reliability and intelligence of high-stakes business decisions, today announced the signing of a definitive agreement to obtain a $2.2 million strategic investment lead by Catheter Precision, Inc. (NYSE:VTAK), and other institutional investors with experience investing in artificial intelligence and emerging technology companies.

    The investment of restricted common stock will strengthen Volato's balance sheet and supports the Company's renewed focus on artificial intelligence, including the evaluation of potential acquisition and merger opportunities in AI infrastructure, AI software, data infrastructure, compute, power generation, and related sectors.

    The investment is subject to certain customary closing conditions, including without limitation the authorization of a supplemental listing application filed by Volato with the NYSE American stock exchange.

    The investment follows the recent termination of Volato's previously announced transaction with M2i Global. Volato believes the termination does not alter its ability to pursue the milestones under its accepted NYSE American compliance plan, and management remains focused on executing that plan while pursuing opportunities designed to enhance long-term shareholder value.

    Volato has received two unsolicited non-binding letters of intent related to potential transactions within the artificial intelligence ecosystem, including opportunities involving AI data center infrastructure and power generation assets supporting AI workloads. No definitive agreements have been executed, and there can be no assurance that either opportunity will result in a completed transaction. However, management believes these opportunities support the Company's decision to pursue an AI-focused strategy and reflect the breadth of opportunities emerging across the AI infrastructure sector.

    "The termination of the M2i transaction gives us the opportunity to refocus on a market opportunity we believe is more closely aligned with Volato's technology assets, public-company platform, and long-term shareholder value," said Matt Liotta, Chief Executive Officer of Volato. "We already own and operate an AI software company through Parslee, and we are now actively evaluating opportunities in AI infrastructure. This investment was made after we communicated our AI-focused strategy, and we believe that is an important signal. These investors are backing our future direction, strengthening our balance sheet, and providing additional flexibility as we evaluate acquisition targets and strategic transactions in the AI infrastructure sector."

    Volato currently owns Parslee, an AI software platform focused on improving the reliability and auditability of AI systems through deterministic document intelligence technology. The Company is also developing Volato AI, an initiative that combines Parslee's technology with Volato's operational experience in aviation to develop specialized AI agents and software for the aviation industry. Together, these initiatives provide the Company with direct operating experience in artificial intelligence as it evaluates larger opportunities within the AI infrastructure ecosystem.

    "We are excited to support Volato as its now largest shareholder as it executes on its AI strategy," said David Jenkins, Chief Executive Officer of Catheter Precision. "We believe the Company possesses a unique combination of AI technology assets, industry expertise, and public market access. We look forward to supporting management as it pursues opportunities in the rapidly evolving AI sector."

    Volato intends to continue evaluating opportunities in AI infrastructure, AI software, data infrastructure, compute, power generation, and related sectors that could enhance shareholder value and further align the Company's public market platform with its long-term strategic direction.

    Additional details regarding the transaction will be provided in the Company's Current Report on Form 8-K.

    About Volato

    Volato Group, Inc. (NYSE:SOAR) is a technology company focused on building scalable software and data solutions that improve the reliability and intelligence of high-stakes business decisions. The Company's existing Parslee Document Intelligence platform enhances the performance of leading large language models by adding deterministic structure and auditability to complex documents such as contracts and SEC filings. For more information, visit www.flyvolato.com.

    No Offer or Solicitation

    This communication is for information purposes only and is not intended to and does not constitute, or form part of, an offer, invitation or the solicitation of an offer or invitation to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of any securities, or the solicitation of any vote or approval in any jurisdiction, pursuant to the proposed transactions or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. The proposed investment is expected to close solely pursuant to legally binding definitive agreements containing the material terms and conditions of the proposed investment. No offer of securities shall be made except by means of a prospectus meeting the requirements of the Securities Act of 1933, as amended, or an exemption therefrom.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements include statements regarding the Company's strategic investment, intended use of proceeds, AI-focused strategy, evaluation of acquisition and merger opportunities, potential transactions, non-binding letters of intent, AI infrastructure opportunities, NYSE American compliance plan, business strategy, and potential shareholder value creation.

    Forward-looking statements can often be identified by words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates," "projects," "targets," "would," "will," "should," "could," "may," "potential," "opportunity," "evaluate," and similar expressions.

    Forward-looking statements are based on current expectations, assumptions, estimates, and projections and are not guarantees of future performance or events. Actual results may differ materially from those expressed or implied by these forward-looking statements as a result of various risks and uncertainties, including the risk that the Company may not enter into or complete any acquisition, merger, financing, or other strategic transaction; that non-binding letters of intent may not result in definitive agreements; that any potential transaction may be subject to regulatory, financing, shareholder, third-party, diligence, market, or other conditions; that AI infrastructure opportunities may involve substantial capital requirements, operational complexity, power availability, regulatory approvals, and integration risks; that the Company may not regain or maintain compliance with NYSE American continued listing standards; that the Company's stock price may experience volatility; and the other risks described in the Company's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the fiscal year ended December 31, 2025, subsequent reports filed with the SEC, and other filings the Company may make from time to time.

    All forward-looking statements speak only as of the date they are made. Volato undertakes no obligation to update or revise any forward-looking statement, except as required by law.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260608478383/en/

    Investor Contact:

    investors@flyvolato.com

    Get the next $SOAR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SOAR
    $VTAK

    CompanyDatePrice TargetRatingAnalyst
    More analyst ratings

    $SOAR
    $VTAK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Operating Officer Prachar Michael Patrick bought $988 worth of shares (1,235 units at $0.80) (SEC Form 4)

    4 - Volato Group, Inc. (0001853070) (Issuer)

    6/10/24 6:38:24 PM ET
    $SOAR
    Transportation Services
    Consumer Discretionary

    Chief Executive Officer Liotta Matthew bought $4,860 worth of shares (6,000 units at $0.81), increasing direct ownership by 0.13% to 4,797,271 units (SEC Form 4)

    4 - Volato Group, Inc. (0001853070) (Issuer)

    6/10/24 6:35:35 PM ET
    $SOAR
    Transportation Services
    Consumer Discretionary

    Chief Financial Officer Heinen Mark bought $6,800 worth of shares (8,500 units at $0.80) (SEC Form 4)

    4 - Volato Group, Inc. (0001853070) (Issuer)

    6/10/24 6:15:33 PM ET
    $SOAR
    Transportation Services
    Consumer Discretionary

    $SOAR
    $VTAK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Flyte (VTAK) Makes Strategic Investment in Volato (SOAR)

    ATLANTA, June 08, 2026 (GLOBE NEWSWIRE) -- Flyte, the regional air mobility subsidiary of Catheter Precision, Inc. (NYSE:VTAK), focused on making private aviation more accessible and flexible for modern travelers, today announced that it has made a strategic investment in Volato Group, Inc. (NYSE:SOAR). As part of the transaction, VTAK acquired approximately 2.9 million shares of SOAR and will own approximately 7.5% of the company's outstanding common stock. This investment provides a basis to explore potential future collaboration to improve access, efficiency, and innovation across private aviation. "This strategic investment represents an exciting opportunity for both organizations,"

    6/8/26 10:43:33 AM ET
    $SOAR
    $VTAK
    Transportation Services
    Consumer Discretionary
    Medical/Dental Instruments
    Health Care

    Volato Group Announces $2.2 Million Strategic Investment and AI Infrastructure Acquisition Focus

    Investment strengthens balance sheet as Company evaluates non-binding AI infrastructure and technology transaction opportunities Volato Group, Inc. (NYSE:SOAR) (the "Company" or "Volato"), a technology company focused on building scalable software and data solutions that improve the reliability and intelligence of high-stakes business decisions, today announced the signing of a definitive agreement to obtain a $2.2 million strategic investment lead by Catheter Precision, Inc. (NYSE:VTAK), and other institutional investors with experience investing in artificial intelligence and emerging technology companies. The investment of restricted common stock will strengthen Volato's balance shee

    6/8/26 6:15:00 AM ET
    $SOAR
    $VTAK
    Transportation Services
    Consumer Discretionary
    Medical/Dental Instruments
    Health Care

    Volato Group Announces NYSE American Acceptance of Compliance Plan

    Volato Group, Inc. (NYSE:SOAR) (the "Company" or "Volato"), a technology company focused on building scalable software and data solutions that improve the reliability and intelligence of high-stakes business decisions, today announced that it has received notice from NYSE Regulation that NYSE American LLC ("NYSE American") has accepted the Company's plan to regain compliance with the NYSE American continued listing standards. The acceptance allows Volato's Class A common stock to continue trading on NYSE American while the Company executes its plan and continues its broader financial and strategic stabilization efforts. As previously disclosed, the Company received notice from NYSE Americ

    6/4/26 9:00:00 AM ET
    $SOAR
    Transportation Services
    Consumer Discretionary

    $SOAR
    $VTAK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Heinen Mark

    4 - Volato Group, Inc. (0001853070) (Issuer)

    3/31/26 8:07:08 AM ET
    $SOAR
    Transportation Services
    Consumer Discretionary

    SEC Form 4 filed by Nichols Mike

    4 - Volato Group, Inc. (0001853070) (Issuer)

    3/31/26 8:07:02 AM ET
    $SOAR
    Transportation Services
    Consumer Discretionary

    SEC Form 4 filed by Burger Christopher

    4 - Volato Group, Inc. (0001853070) (Issuer)

    3/31/26 8:06:56 AM ET
    $SOAR
    Transportation Services
    Consumer Discretionary

    $SOAR
    $VTAK
    SEC Filings

    View All

    Catheter Precision Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - Catheter Precision, Inc. (0001716621) (Filer)

    6/8/26 6:16:04 AM ET
    $VTAK
    Medical/Dental Instruments
    Health Care

    Volato Group Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Volato Group, Inc. (0001853070) (Filer)

    6/8/26 6:15:24 AM ET
    $SOAR
    Transportation Services
    Consumer Discretionary

    Volato Group Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement

    8-K - Volato Group, Inc. (0001853070) (Filer)

    6/5/26 5:00:17 PM ET
    $SOAR
    Transportation Services
    Consumer Discretionary

    $SOAR
    $VTAK
    Leadership Updates

    Live Leadership Updates

    View All

    M2i Global, along with Volato Group, and Titanium X Sign Strategic Collaboration Agreement to Advance Critical Mineral Development in the United States

    Includes Exclusive Supply Agreement of Titanium Concentrate Atlanta, GA and Reno, NV, Jan. 07, 2026 (GLOBE NEWSWIRE) -- M2i Global, Inc. ("M2i," the "Company," "we," "our" or "us") (OTCQB:MTWO), a company specializing in the development and execution of a complete global value supply chain for critical minerals, along with Volato Group, Inc. ("Volato") (NYSE:SOAR), a technology-driven company, is pleased to announce a strategic collaboration agreement with Titanium X, marking a major step forward in advancing domestic refining capabilities and securing the critical materials supply chain essential to U.S. industry and national security. Under the agreement, Titanium X and M2i Global will

    1/7/26 2:00:00 PM ET
    $SOAR
    Transportation Services
    Consumer Discretionary

    Volato Group Appoints Alan D. Gaines to Board of Directors

    Veteran Investment Banker and Energy Industry Leader to Serve as Audit Committee Chairman Volato Group, Inc. (the "Company" or "Volato") (NYSE:SOAR), today announced the appointment of Alan D. Gaines to its Board of Directors, effective immediately. Mr. Gaines will also serve as Chairman of the Audit Committee. Mr. Gaines is an accomplished investment banker, strategic advisor, and entrepreneur with more than four decades of experience in global capital markets, energy, critical minerals, and infrastructure development. Over his career, he has led or participated in more than 200 major transactions, raising over $100 billion in aggregate capital. He is the Executive Chairman, CEO, and

    12/29/25 8:30:00 AM ET
    $SOAR
    Transportation Services
    Consumer Discretionary

    Volato Group's Proposed Acquisition Under Definitive Agreement, M2i Global Names Anthony Roger Moore to its Board of Advisors

    Atlanta, GA and Reno, NV, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Volato Group, Inc. ("Volato") (NYSE:SOAR), a technology-driven private aviation company and M2i Global, Inc. ("M2i Global") (OTCQB:MTWO), a company specializing in the development and execution of a complete global value supply chain for critical minerals, is pleased to announce that Anthony Roger Moore, a global financial services professional with more than 55 years' experience with business transactions spanning over 30 countries, has joined the Company's Advisory Board. M2i's ecosystem provides partners with access to turnkey solutions, facilitating expanded business opportunities, securing offtake agreements, influencing str

    10/1/25 8:30:00 AM ET
    $SOAR
    Transportation Services
    Consumer Discretionary

    $SOAR
    $VTAK
    Financials

    Live finance-specific insights

    View All

    Catheter Precision Reports 2025 Results and Updates on Strategic Expansion

    Clinical, Commercial and Regulatory Milestones Achieved in 2025 Establish a Strong Foundation in Life Sciences as Revenue Increases 95% Year Over Year Acquisition of Flyte and Strengthened Capital Position Unlock Multi-Segment Growth Strategy with Multiple Near-Term Catalysts FORT MILL, S.C., March 31, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE:VTAK) ("VTAK" or the "Company"), a U.S.-based innovative medical device company focused on electrophysiology products, today announced its financial results and operational update for the fourth quarter and full year ended December 31, 2025 as well as certain other business updates. 2025: Execution Across Clin

    3/31/26 8:00:00 AM ET
    $VTAK
    Medical/Dental Instruments
    Health Care

    CRTD (Creatd Inc.) Sells Remaining 80% of Fly Flyte to NYSE-Listed VTAK (Catheter Precision Inc.), Securing Significant Cash and Equity Position

    NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Creatd, Inc. (OTCQB:CRTDD) today announced that it has sold its remaining 80% equity stake in its subsidiary, Fly Flyte, Inc. ("Flyte"), to Catheter Precision, Inc. (NYSE:VTAK). Under the terms of the completed transaction, Creatd will receive approximately $6,000,000 in cash and nearly $6,000,000 in Convertible Preferred Stock of VTAK. The NYSE-approved transaction considerably strengthens Creatd's balance sheet. The sale is consistent with Creatd's strategy of developing turnkey operating solutions that prepare businesses for listing on the public markets while simultaneously retaining a minority interest in them. The transaction positions Cr

    3/10/26 8:00:00 AM ET
    $VTAK
    Medical/Dental Instruments
    Health Care

    VTAK Acquires 20% Interest in Creatd's Subsidiary Fly Flyte, Inc.

    Strategic Partnership: Creatd expanded Fly Flyte's investor network by adding NYSE-listed VTAK as an investor in its subsidiary.Portfolio Expansion: Creatd continues advancing its portfolio strategy through multiple active acquisition discussions.Innovation in Aviation: Fly Flyte, Inc. is transforming regional aviation through accessibility, convenience, and technology-driven operations. NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Creatd, Inc. (OTCQB:CRTD) announced that Catheter Precision, Inc. (NYSE:VTAK) has acquired a 20% equity interest in Fly Flyte, Inc., its subsidiary, through a secondary purchase from an existing shareholder. The transaction aligns with Creatd's strategy of nurtu

    2/17/26 2:17:42 PM ET
    $CRTD
    $VTAK
    Publishing
    Consumer Discretionary
    Medical/Dental Instruments
    Health Care

    $SOAR
    $VTAK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Catheter Precision Inc.

    SC 13G/A - Catheter Precision, Inc. (0001716621) (Subject)

    11/14/24 5:12:56 PM ET
    $VTAK
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Volato Group Inc.

    SC 13G/A - Volato Group, Inc. (0001853070) (Subject)

    11/14/24 7:58:49 AM ET
    $SOAR
    Transportation Services
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Catheter Precision Inc.

    SC 13G/A - Catheter Precision, Inc. (0001716621) (Subject)

    11/13/24 11:14:58 AM ET
    $VTAK
    Medical/Dental Instruments
    Health Care